A5102215882- Platelet Disorders and Treatments
- Hemophilia Treatment and Research
- Blood groups and transfusion
- Complement system in diseases
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Blood Coagulation and Thrombosis Mechanisms
- Pneumonia and Respiratory Infections
- Streptococcal Infections and Treatments
- Respiratory viral infections research
- Blood properties and coagulation
- Chronic Myeloid Leukemia Treatments
- Cancer-related gene regulation
- Autoimmune and Inflammatory Disorders Research
- Neonatal Health and Biochemistry
- Venous Thromboembolism Diagnosis and Management
- Adolescent and Pediatric Healthcare
- Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Caveolin-1 and cellular processes
- Lipid metabolism and disorders
- Cytomegalovirus and herpesvirus research
- Genital Health and Disease
- Hematopoietic Stem Cell Transplantation
- Lung Cancer Research Studies
- Periodontal Regeneration and Treatments
- Immune Cell Function and Interaction
Beijing Children’s Hospital
2009-2025
Capital Medical University
2009-2025
Analysis and Testing Centre
2007
Czech Academy of Sciences, Biology Centre
2007
With the increase of awareness mycoplasma pneumoniae pneumonia (MPP), we found thrombosis in severe MPP (SMPP) was not rare. The aim study to investigate clinical characteristics, treatment, and long-term prognosis MPP-associated thrombosis.We retrospectively reviewed medical records 43 children with between January 2013 June 2019 at Beijing Children's Hospital. results blood coagulation studies, autoimmune antibody, thrombophilia screening, contrast-enhanced lung computed tomography,...
Background: Although much attention has been paid to the pharmacokinetics (PKs) of different factor VIII (FVIII) concentrates in persons with hemophilia A (HA), limited information is available young boys severe HA. In this study, we aimed assess PK parameters FVIII products HA China. Methods: total 36 (plasma-derived [pd]-FVIII, n = 15; recombinant [r] FVIII, 21) were enrolled between January 2015 and May 2016 Beijing Children's Hospital. characteristics studied according a reduced...
The efficacy and safety of recombinant human thrombopoietin (rhTPO) in children adolescent patients with chronic primary immune thrombocytopenia (ITP) remains unclear. A multicentre, randomized, double-blind, placebo-controlled phase III trial was performed. Patients aged 6-17 years, diagnosed ITP resistant or relapsed to corticosteroid treatment were included. For the trial, part 1 exploratory 2 main analysis, determining whether stratified by age. treated rhTPO (the 6- 11-/12- 17-year-old...
Objective To analyze the diagnostic status of haemophilia in Chinese children recent years, and to provide information for increasing life quality with China. Methods The pediatric cases registration data were collected analyzed by using questionnaire, from January 1, 2008 March 30, 2014 13 treatment centers center collaboration network China group.These 12 provinces / municipalities. Results A total 554 collected; median age was 7.0 years old(0.1 17.9 old); among them, 481...